Identifying Genetic Variants in Metachromatic Leukodystrophy in Morocco
Author Information
Author(s): Hammoud Miloud, Domínguez-Ruiz María, Assiri Imane, Rodrigues Daniel, Aboussair Nisrine, Lanza Val F., Villarrubia Jesús, Colón Cristóbal, Fdil Naima, del Castillo Francisco J.
Primary Institution: Cadi Ayyad University, Marrakech, Morocco
Hypothesis
Can next-generation sequencing (NGS) effectively identify genetic variants in patients with suspected metachromatic leukodystrophy?
Conclusion
The study identified novel and known pathogenic variants in the ARSA gene associated with metachromatic leukodystrophy in Moroccan patients.
Supporting Evidence
- Next-generation sequencing techniques can significantly reduce the time to diagnosis for rare diseases.
- Three patients were diagnosed with metachromatic leukodystrophy through a combination of biochemical and genetic testing.
- Two novel and one known pathogenic variants in the ARSA gene were identified in the affected families.
- Biochemical assays confirmed low arylsulfatase A activity in patients, supporting the genetic findings.
- Consanguinity was common among the families studied, which may have contributed to the genetic findings.
Takeaway
This study found genetic changes in patients with a rare brain disease, helping doctors understand and diagnose it better.
Methodology
The study used biochemical analyses, next-generation sequencing, and splicing assays to diagnose metachromatic leukodystrophy in patients.
Limitations
The study may not account for all genetic variations due to the focus on specific genes and the limited sample size.
Participant Demographics
Patients ranged in age from 18 days to 59 years, with a median age of 4 years; many were from consanguineous families.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website